A new economic study has found that cancer types that were the focus of articles receiving public or private research support had fewer hospitalizations and lower mortality.
A new economic study has found that cancer types that were the focus of more articles receiving public or private research support had fewer hospitalizations and years of potential life lost.
Prior work had shown that cancer mortality rates may be inversely related to the amount of research-funded literature about each cancer type, and that this association grew stronger as more years passed since the articles’ publication. In a follow-up, the lead author of that 2013 study set out to analyze whether research support for various types of cancer was associated with a decline in years of potential life lost or hospitalizations from 1999 to 2013. The findings were published by the National Bureau of Economic Research.
Examining years of potential life lost as opposed to mortality rates would “enable us to calculate the number of life-years gained from biomedical research,” wrote study author Frank R. Lichtenberg. He also chose hospitalizations as another outcome due to its substantial cost burden, as it accounted for almost one-third of American medical expenditure in 2014.
For the analysis, Lichtenberg conducted difference-in-differences models based on longitudinal data for 30 different cancer sites, such as respiratory neoplasms, myeloid leukemia, and non-Hodgkin lymphoma. He collected data for each type of cancer on the years of potential life lost before age 55, 65, and 75; number of hospital discharges and days of care; number of PubMed articles with that site as a “main topic” that mentioned either federal or nonfederal support, as well as those that did not mention such support; and general incidence data.
He found that premature mortality before age 75 was inversely related to the number of research-supported articles that had been published 9 to 15 years earlier. This relationship was similar for premature mortality before age 65 and research-supported articles published 12 to 15 years earlier, as well as before age 55 and research-supported articles published 18 to 24 years later. There was no association between years of potential life lost before any age and the number of publications that did not have research support.
Both, hospital discharges and inpatient days for the cancer types were also inversely related to the number of research-funded publications. For example, for each additional 1000 research-supported articles, there was a 10% reduction in discharges 24 years later.
According to Lichtenberg, these findings “indicate that cancer sites about which more research-supported articles were published since the 1970s had larger reductions in premature mortality and hospitalization during the period 1999-2013, controlling for the change in the number of people diagnosed.”
If no research-funded articles had been published from 1987 to 2001, he estimated there would have been 566,000 additional potential years of life lost due to cancer before age 75. Additionally, the support for research articles published from 1984 to 1998 reduced hospital discharges by an average of 4.1% each year from 1999 to 2013.
Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities
April 22nd 2025Researchers are calling for more targeted efforts to improve health equity after a new analysis revealed that cancer symptom documentation and burden vary across certain demographics.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers
April 21st 2025The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was particularly heightened among patients with severe mucous membrane pemphigoid.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More